Method of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based on a trained machine learning classifier
US11195595B2 · kind B2 · utility
4Cited by
19References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2021 |
| Grant date | Dec 7, 2021 |
| Priority date | — |
| Expiry date | May 10, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Presented herein are systems and methods for developing classifiers useful for predicting response to particular treatments. For example, in some embodiments, the present disclosure provides a method of treating subjects suffering from an autoimmune disorder, the method comprising a step of: administering an anti-TNF therapy to subjects who have been determined to be responsive via a classifier established to distinguish between responsive and non-responsive prior subjects in a cohort who have received the anti-TNF therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.